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Abstract 
We herein report a rare case of squamous cell carcinoma of the hilar bile duct. A 
66-year-old Japanese male patient was admitted to our hospital because of appetite loss 
and jaundice. Abdominal computed tomography revealed an enhanced mass measuring 
10 × 30 mm in the hilar bile duct region. After undergoing biliary drainage, the patient 
underwent extended right hepatic lobectomy with regional lymph nodes dissection. The 
tumor had invaded the right portal vein. Therefore, we also performed resection and 
reconstruction of the portal vein. Histopathologically, the carcinoma cells exhibited a 
solid structure with differentiation to squamous cell carcinoma with keratinization and 
intercellular bridges. Immunohistochemical staining of the tumor cells revealed positive 
cytokeratin staining and negative CAM 5.2 staining. Based on these findings, a definitive 
diagnosis of well-differentiated squamous cell carcinoma of the hilar bile duct was made. 
 
Introduction 
Cases of biliary tract cancer are usually adenocarcinoma tumors. Although there have 
been many reported cases of adenosquamous carcinoma, there have been few reported 
cases of pure squamous cell carcinoma with no adenocarcinoma components, and the 
majority of these cases are already advanced at the time of diagnosis. According to 
Funakawa et al. [1], the incidence of squamous cell carcinoma arising in the extrahepatic 
bile duct is less than 1.4%. The first case of squamous cell carcinoma of the bile duct was 
reported by Cabot [2] in 1930. Since then, only 15 cases of squamous cell carcinoma 
originating in the extrahepatic bile duct have been reported, including the present case. 
We herein report a case of primary squamous cell carcinoma at the bifurcation level that 
may be only the 6th such case published in the literature, thus indicating that this Case Rep Gastroenterol 2011;5:463–470 
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condition is very rare. Due to the rare nature of the diagnosis, little information is 
available regarding the optimal management of these tumors. We describe this case while 
also reviewing the pertinent literature. Furthermore, we also discuss the potential 
mechanisms underlying squamous cell carcinoma of the biliary tree and the clinical 
characteristics and significance of chemotherapy or radiation therapy, and the prognosis. 
Case Report 
A 66-year-old Japanese male patient was admitted to our hospital because of appetite loss and 
jaundice. Physical examination revealed mild icteric sclerae. The patient’s medical history was 
unremarkable. Laboratory data showed abnormal values for total bilirubin at 11.0 mg/dl (normal range 
0.3–1.2), alkaline phosphatase of 2,278 IU/l (normal range 115–359), serum glutamic oxaloacetic 
transaminase of 175 IU/l (normal range 13–33), serum glutamic pyruvic transaminase of 287 IU/l 
(normal range 6–30), and C-reactive protein of 9.61 mg/dl (normal range <0.2), while all other 
laboratory data examined were within the normal ranges. The levels of carbohydrate antigen 19-9 
(CA19-9) were 2,610 ng/ml (normal range <37), SPan-1 was 584 ng/ml (normal range <30), and 
DUPAN-2 was 508 ng/ml (normal range <150), while carcinoembryonic antigen at 2.6 ng/ml (normal 
range <5) was within normal range. Abdominal computed tomography (CT) revealed an enhanced 
mass measuring 10 × 30 mm in the hilar bile duct portion of the extrahepatic bile duct (fig. 1). MRI 
cholangiopancreatography revealed a defect from the junction of the common bile duct and the cystic 
duct to the bilateral hepatic duct. The patient underwent percutaneous transhepatic biliary drainage in 
the left lateral superior segmental duct (B3) and the right anterior inferior segmental duct (B5) for 
alleviation of the jaundice and evaluation of the biliary system (fig. 2). A percutaneous transhepatic 
cholangiogram revealed an obstruction of the first-order branch of the left bile duct, the anterior 
segmental bile duct and the posterior segmental bile duct. A diagnosis of a malignant tumor in the 
hilar bile duct was made, and the patient underwent extended right hepatic lobectomy with regional 
lymph node dissection. At laparotomy, an elastic hard mass was found in the hilar bile duct. The tumor 
had invaded the right portal vein. Therefore, we performed resection and reconstruction of the portal 
vein in addition. A choledochojejunostomy of B2+B3, B4 was performed using the Roux-en-Y method.  
The resected specimen exhibited the nodular invasion type, measured 10 × 30 mm and had 
partly invaded to the portal vein and liver (fig. 3). Histopathologically, HE staining revealed that 
the tumor cells were arranged via keratinization and intercellular bridges (fig. 4). There was one 
lymph node metastasis at the cystic duct, and no carcinoma was present at the surgical margin of the 
left hepatic duct. Immunohistochemical staining of the tumor cells revealed positive cytokeratin 
staining and negative CAM 5.2 staining (fig. 5). Based on these findings, a definitive diagnosis of a 
well-differentiated squamous cell carcinoma of the hilar bile duct was made.  
Six months after the operation, serum CA19-9 levels rapidly increased. Abdominal CT and 
18F-fluorodeoxyglucose positron emission tomography were performed and revealed solitary liver 
metastasis. First-line chemotherapy with cisplatin (80 mg/m
2 on day 1 every 4 weeks) and 5-fluorouracil 
(800 mg/m
2 on days 1–5 every 4 weeks) was stopped because severe side effects (nausea and high fever) 
occurred. Second-line chemotherapy with gemcitabine (600 mg/m
2 on days 1, 8 and 15 every 4 weeks) 
and S-1 (80 mg/day for 14 days followed by 7 days of rest) was administered for 3 months. However, the 
metastatic tumor progressively increased. The patient succumbed to progressive hepatic metastasis 
12 months after the operation. 
Discussion 
The majority of malignant tumors arising in the biliary tree are adenocarcinomas; 
squamous cell carcinomas are very rare. The potential mechanisms of squamous cell 
carcinoma of the biliary tree include transformation of the adenocarcinoma to squamous 
cell carcinoma, derivation from metaplastic squamous epithelium of the glandular tissue, 
derivation from ectopic squamous epithelium, and derivation from undifferentiated basal Case Rep Gastroenterol 2011;5:463–470 
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cells [1]. In a study on adenosquamous carcinoma, which occurs relatively frequently in 
cases of gallbladder cancer, Kohno et al. [3] observed images of tissue migration from 
adenocarcinoma to squamous cell carcinoma and found that the growth rate of squamous 
cell carcinoma exceeded that of adenocarcinoma, thus suggesting that adenocarcinoma 
can transform into squamous cell carcinoma. However, since Cabot [2] developed the 
theory of canceration from squamous metaplasia of the biliary mucosa caused by 
inflammatory irritation, derivation from metaplastic squamous epithelium of glandular 
tissue has been considered to be the primary mechanism, and this hypothesis has been 
primarily supported by cases of pure squamous cell carcinoma with no adenocarcinoma 
components. Sewkani et al. [4] have listed ascariasis, choledochal cyst, Caroli disease, and 
primary sclerosing cholangitis as causative diseases. According to Hayafuchi and Kato [5], 
there is an undifferentiated basal cell layer in cases of cholecystitis complicated by 
gallstones, and the authors hypothesize that this layer contributes to squamous cell 
carcinoma of the gallbladder. In the present case, the immunostaining analyses revealed 
that the entire tumor was positive for cytokeratin and negative for CAM 5.2, and 
squamous cell carcinoma was observed in all cells of the cancerous region. Furthermore, 
because no images of metaplastic changes to squamous epithelium or migration from 
adenocarcinoma to squamous cell carcinoma were observed, it was difficult to explain the 
present mechanism. 
There have been few reported cases of extrahepatic bile duct cancer patients who 
presented with histological findings of squamous epithelium, and since Cabot [2] 
reported the first case in 1930, there have been 15 cases, including the present patient, 
indicating the rarity of this condition (table 1). The ages of the patients ranged from 24 
to 86 years (mean 62.9), and 10 male and 5 female subjects were reported. The site of 
occurrence was the hilar region in 6 cases, the proximal region in 2 cases, the distal region 
in 6 cases, and an unknown region in 1 case, and many of these tumors were observed in 
the hilar bile duct and the distal bile duct. The methods of diagnosis included 
postoperative histopathological diagnosis in 9 cases, biopsy in 3 cases [4, 8, 15], and 
autopsy in 3 cases. Consequently, the possibility that the 3 biopsied cases were also 
adenosquamous carcinoma cannot be ruled out. Surgical treatment was performed in 
9 cases and included 6 cases of pancreaticoduodenectomy, 2 cases of extended left hepatic 
lobectomy, and 1 case of extended right hepatic lobectomy, while other treatments 
included palliative therapy such as bypass surgery, biliary stenting and chemoradiation 
therapy. The mean patient survival period was 11.1 months (range 3–27).  
Squamous cell carcinoma of the biliary tree is characterized by the fact that the cell 
properties and prognosis differ depending on the site of occurrence of the tumor. 
Compared to cases of adenocarcinoma, cases of squamous cell carcinoma of the 
gallbladder tend to be locally limited, despite a large tumor diameter, and are more 
susceptible to tumor mass formation and invasion into neighboring organs with a low 
rate of hematogenous or lymphatic metastasis [18]. Therefore, a good prognosis can be 
expected by performing complete resection with lymph node dissection. At the same 
time, regarding intrahepatic cholangiocarcinoma, Nakajima and Kondo [19] compared 
11 cases of intrahepatic cholangiocarcinoma involving squamous and adenosquamous 
carcinoma and 82 cases of adenocarcinoma, and concluded that the former cases tend to 
be discovered as advanced cancer with a large tumor diameter, present with widespread 
metastasis and have a poor prognosis. At the same time, regarding squamous cell 
carcinoma of the extrahepatic bile duct, it is difficult to systematically assess the Case Rep Gastroenterol 2011;5:463–470 
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characteristics because there are so few cases of these tumors. Based on these previous 
cases, there are many advanced tumors, including hepatic metastasis, vascular invasion, 
lymph node metastasis, and local invasion into the surrounding organs, and it was 
assumed that the patient prognosis is poor. Aranha et al. [8] have reported that 
development similar to adenocarcinoma is observed, invasion outside the bile duct 
and liver invasion occur progressively, and there is a tendency of metastasis to the 
local lymph nodes. Moreover, Okabayashi et al. [20] performed a comparative study 
of adenocarcinoma and adenosquamous carcinoma of the extrahepatic bile duct, thus 
concluding that adenocarcinoma progressed faster and had a higher malignancy 
compared to adenosquamous carcinoma. In the present case, the tumor diameter was 
10 × 30 mm, there was marked local invasion including lymph node metastasis at the 
cystic duct, and vascular invasion into the main trunk of the right portal vein was 
observed. The histological findings included well-defined invasion into the liver 
parenchyma, and vascular invasion into the portal vein was observed. Therefore, the 
hepatic metastasis that occurred 6 months after the operation was suggestive of 
hematogenous metastasis caused by portal invasion. 
There is no established chemotherapy or radiation therapy for squamous cell 
carcinoma of the biliary tree. Various treatments have been used in reported cases of 
squamous cell carcinoma of the gallbladder, including UFT+brisplatin, MF therapy, 
5-fluorouracil arterial injection, and MFC therapy [21]. There have been only 2 reported 
cases of chemotherapy for squamous cell carcinoma of the extrahepatic bile duct, and 
there are also cases of concomitant and sequential administration of 4 agents comprising 
cyclophosphamide, doxorubicin, methotrexate [6], and procarbazine and cases of FP 
therapy [10]. Moreover, regarding radiation therapy, Abbas et al. [16] reported a case of 
squamous cell carcinoma of the hilar bile duct treated with intraoperative irradiation of 
the resection stump and external radiation for 6 weeks after operation, and the patient 
survived for 18 postoperative months. In the present patient, our policy was to conduct a 
postoperative follow-up examination, but because recurrence was observed 6 months 
after operation, the patient was treated with postoperative chemotherapy (first line: 
cisplatin and 5-fluorouracil, second line: S-1 and gemcitabine). From approximately 
11 months after operation, marked general malaise and anorexia were observed, and 
approximately 12 months after operation, the patient succumbed to the disease. We 
therefore conclude that it is necessary to carefully investigate the indications of 
postoperative adjuvant chemotherapy and radiation therapy, and the details of 
chemotherapy when considering the properties of squamous cell carcinoma. 
Conclusion 
We reported in this paper a case of squamous cell carcinoma of the hilar bile duct and 
reviewed the previous reports. The majority of malignant tumors arising in the biliary tree 
are adenocarcinomas; squamous cell carcinomas are very rare. The majority of these cases 
are already advanced at the time of diagnosis. Based on these previous cases, there are 
many advanced tumors, including hepatic metastasis, vascular invasion, lymph node 
metastasis, and local invasion into the surrounding organs, and it is assumed that the 
prognosis is poor. 
 
 Case Rep Gastroenterol 2011;5:463–470 
DOI: 10.1159/000331051 
Published online: 
August 22, 2011 
© 2011 S. Karger AG, Basel
ISSN 1662–0631 
www.karger.com/crg   
 
 
 
467
 
Table 1. 15 cases of squamous cell carcinoma of the extrahepatic bile duct 
First author   Year  Age  Sex  Position   Operation   Chemo- 
therapy  
Radia-
tion 
Prognosis  
Cabot [2]  1930  58  M  proximal  unknown  x  x  unknown 
Burger [6]  1978  24  F  distal  pancreaticoduodenectomy  y  x  8 m, dead 
Gulsrud [7]  1979  68  M  unknown  cholecystectomy with T tube  x  x  6 m, dead 
Aranha [8]  1980  58  F  hilar  T tube, cholecystectomy  x  y  3 m, dead 
Clements [9]  1990  73  M  hilar  biliary stent  x  x  unknown 
Hirayasuyama [10]  1990  68  M  distal  pancreaticoduodenectomy  y  x  3 m, alive 
Sakata [11]  1991  68  M  distal  pancreaticoduodenectomy  x  x  2 y 3 m, alive  
Shibata [12]  1994  50  M  hilar  extended left hepatic lobectomy  x  x  10 m, alive 
Nakazaki [13]  1996  75  M  distal  pancreaticoduodenectomy  x  x  6 m, alive 
Cho [14]  2000  63  M  distal  pancreaticoduodenectomy  x  x  unknown 
Gatof [15]  2004  86  F  proximal  cholecystectomy, biliary stent  x  y  18 m, dead 
Sewkani [4]  2005  60  M  distal  pancreaticoduodenectomy   x  x  unknown 
Abbas [16]  2008  86  F  hilar  extended left hepatic lobectomy  x  y  18 m, alive 
Price [17]  2008  41  F  hilar  biliary stent  y  y unknown 
Our case  2010  66  M  hilar  extended right hepatic lobectomy  y  x  12 m, dead 
 
 
 
 
 
Fig. 1. Abdominal CT showed a mass measuring 10 × 30 mm in the hilar bile duct. This figure show a 
10 × 10 mm tumor (arrow). 
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Fig. 2. A percutaneous transhepatic cholangiogram revealed an obstruction of the first-order branch of 
the left bile duct, the anterior segmental bile duct and the posterior segmental bile duct. 
 
 
Fig. 3. Macroscopically, the tumor was of the nodular invasion type, measured 10 × 30 mm and partly 
invaded the portal vein and the liver. 
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Fig. 4. Histopathologically, HE staining showed the tumor cells arranged via keratinization and 
intercellular bridges. 
 
 
Fig. 5. Immunohistochemical staining of the tumor cells showed cytokeratin (positive) and CAM 5.2 
(negative) reactions. a Cytokeratin, 40× magnification. b CAM 5.2, 40× magnification. 
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